NAT1 Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.
Synonyms
AAC1; Arylamide acetylase 1; mNAT; N acetyltransferase type 1; nat1.
Gene ID
9
Swiss Prot
P18440
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human
Target
NAT1
Clonality
Recombinant
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human NAT1
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
042492-ML550 100 µL
SURF4, CT (Surfeit Locus Protein 4, SURF-4, ERV29, FLJ22993, MGC102753) (MaxLight 550) discontinued
Ask
View Details ![2- (2,3-Dihydro-benzo[1,4]dioxine-6-sulfonyl) -1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
sc-339581 250 mg
2- (2,3-Dihydro-benzo[1,4]dioxine-6-sulfonyl) -1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid
Ask
View Details